| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/06/2006 | EP1698694A1 Method of obtaining gene tag |
| 09/06/2006 | EP1698693A1 Royal jelly peptide and composition containing the same |
| 09/06/2006 | EP1698691A1 Growth factor mutants with improved biological activity |
| 09/06/2006 | EP1698690A1 Basal medium for es cell culturing |
| 09/06/2006 | EP1698639A2 Pluripotency determining factors and uses thereof |
| 09/06/2006 | EP1698358A1 Transplantable biomaterial and method of preparing the same |
| 09/06/2006 | EP1698347A2 hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/06/2006 | EP1697715A2 Identification, isolation and elimination of cancer stem cells |
| 09/06/2006 | EP1697542A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 09/06/2006 | EP1697519A2 Sesquiterpene synthases from patchouli |
| 09/06/2006 | EP1697506A1 Method for isolating cells from mammary secretion |
| 09/06/2006 | EP1697505A1 Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| 09/06/2006 | EP1697504A1 Use of il-6-type cytokines for maturation of oocytes |
| 09/06/2006 | EP1697503A2 Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23 |
| 09/06/2006 | EP1697502A2 Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
| 09/06/2006 | EP1697501A2 Method for in vitro differentiation of neuronal stem cells or cells derived from neuronal stem cells |
| 09/06/2006 | EP1697500A1 Stem cells |
| 09/06/2006 | EP1697496A1 Drug testing system with bio-artificial liver |
| 09/06/2006 | EP1697414A2 Process for the production of tumor necrosis factor-binding proteins |
| 09/06/2006 | EP1696976A2 Methods and composition for soft tissue feature reconstruction |
| 09/06/2006 | EP1696945A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 09/06/2006 | EP1696721A2 Dominant gene suppression transgenes and methods of using same |
| 09/06/2006 | EP1648999A4 Systems and methods for separating and concentrating regenerative cells from tissue |
| 09/06/2006 | EP1539928A4 Cd56 positive human adult pancreatic endocrine progenitor cells |
| 09/06/2006 | EP1534818A4 Method of immobilization of clusters of ligands on polymer surface and use n cell engineering |
| 09/06/2006 | EP1444328A4 Induction of beta cell differentiation in human cells |
| 09/06/2006 | EP1153543B1 Animals which are deficient in expressing uridine-phosphorylase |
| 09/06/2006 | EP1127149B1 Cells for the production of helper dependent adenoviral vectors |
| 09/06/2006 | EP1088075B1 Aav structural protein, production and use thereof |
| 09/06/2006 | EP0981601B1 Methods for cultivating cells and propagating viruses |
| 09/06/2006 | EP0815204B1 Method for treating tumors by alloactivated human donor lymphocytes |
| 09/06/2006 | EP0789762B1 Methods for the diagnosis of glaucoma |
| 09/06/2006 | EP0760857B9 Receptor for oncostatin m |
| 09/06/2006 | CN1829798A Protease, DNA coding for the protease and process for producing the protease |
| 09/06/2006 | CN1829796A Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cDNA therefrom, and use thereof |
| 09/06/2006 | CN1829795A Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 09/06/2006 | CN1829791A 皮肤再生系统 Skin Regeneration System |
| 09/06/2006 | CN1829740A Connective tissue growth factor antibodies |
| 09/06/2006 | CN1829667A Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems |
| 09/06/2006 | CN1829533A Antibodies and fusion proteins that include engineered constant regions |
| 09/06/2006 | CN1829530A Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds |
| 09/06/2006 | CN1827766A In vitro cell cultivation method |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1826878A Tissue-culturing rapid propagation method of Actinidia macrosperma |
| 09/06/2006 | CN1826876A Method for inducing and cultivating hairy root system of Saussurea medusa |
| 09/06/2006 | CN1273604C Method of improving gene transfer efficiency into plant cells |
| 09/06/2006 | CN1273598C Bactericidal/permeability-increasing protein delation analogs |
| 09/06/2006 | CN1273586C Novel 'beta'-l-4N-acetylglucosaminyltransferase and gene encoding the same |
| 09/06/2006 | CN1273507C Coating material for leukocyte removal filter and the filter material |
| 09/06/2006 | CN1273192C Method and composition for altering a T cell mediated pathology |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/05/2006 | US7102064 Hybrid maize 34A15 |
| 09/05/2006 | US7102063 Hybrid maize plant and seed 39M79 |
| 09/05/2006 | US7102059 Isolated nucleic acid molecule containing one open reading frame; a nucleotide sequence, or a complementary sequence encoding proteins or polypeptides of Pseudomonas CEL and EEL genomic regions or hybridizes to a DNA molecule |
| 09/05/2006 | US7102058 Phytic acid biosynthetic enzymes |
| 09/05/2006 | US7102057 Nucleotide sequences coding multiple enzymatic activities for use in grain, food and beverage processing and flavoring; fermentation of ethanol/alcoholic beverages |
| 09/05/2006 | US7102056 Compositions and methods for plant transformation and regeneration |
| 09/05/2006 | US7101985 Methods and compositions in checkpoint signaling |
| 09/05/2006 | US7101984 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/05/2006 | US7101980 Derivatives, conjugates, and antibodies for detecting ecstasy-class analytes |
| 09/05/2006 | US7101979 Antibodies to antiangiogenic compositions and methods |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101971 Erythropoietin analog-human serum albumin fusion |
| 09/05/2006 | US7101962 Antibodies of the P2Y10 receptor useful in altering T lymphocyte function |
| 09/05/2006 | US7101850 WISP polypeptides and nucleic acids encoding same |
| 09/05/2006 | US7101719 Measurement of a cellular process in preferential cells; obtain cells, separate into vessels, incubate with label, detecting light emission from phosphorescent particles |
| 09/05/2006 | US7101714 Nucleotide sequences coding polypeptide for us e in the diagnosis, prevention and treatment of inflammatory defects |
| 09/05/2006 | US7101712 Plant protein with repeated WD40 motifs, nucleic acid coding for said protein, and uses thereof |
| 09/05/2006 | US7101711 Activating a T gamma 9 delta 2 lymphocyte at a minimum activation concentration of below 100 nM, in vitro by contacting with a 3,4-epoxy-3-methyl-1-butyl diphosphate substituted with a biomolecule |
| 09/05/2006 | US7101710 Amniotic fluid-derived MSCs (AFMSCs) were successfully isolated, cultured, and enriched without interfering with the routine process of fetal karyotyping |
| 09/05/2006 | US7101709 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator |
| 09/05/2006 | US7101708 Hematopoietic cell composition for use in transplantation |
| 09/05/2006 | US7101707 Secondary sprouting for isolation and expansion of endothelial sprout cells and endothelial precursor cells from a mixed population and for screening substances |
| 09/05/2006 | US7101706 Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase |
| 09/05/2006 | US7101705 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 09/05/2006 | US7101704 Expressing a co-stimulatory molecule, treated with interferon- gamma, and modified to have an exogenous antigen fragment bound to MHCII; antigen is presented to initiate an immune response |
| 09/05/2006 | US7101694 Comprises polypeptide which converts oxyluciferin to luciferin for use in medicine and food hygiene |
| 09/05/2006 | US7101689 Interleukin-18 binding proteins, their preparation and use |
| 09/05/2006 | US7101685 Recombinant Sendai virus |
| 09/05/2006 | US7101683 Hepatitis C virus (HCV) proteins; chemiluminescence; genetic engineering |
| 09/05/2006 | US7101680 Method for detecting the presence of monomeric brain associated human glutamine synthetase |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101551 Substance which inhibits binding between E2/NS1 protein of hepatitis C virus and cell infectious with hepatitis C virus, a cell expressing CD81, or CD81 |
| 09/05/2006 | US7101546 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells |
| 09/05/2006 | US7101545 culturing minced human intervertebral cells to form a monolayer, isolating the disc cells from monolayer, dispersing the cells in a carrier, implanting carrier/cells into a target disc area; propagating disc cells in vitro |
| 09/05/2006 | US7101543 Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells |
| 09/05/2006 | US7101540 Targeted retrograde gene delivery to motor neurons |
| 09/05/2006 | CA2143642C Immunoreactive peptides from epstein-barr virus |
| 09/02/2006 | CA2496690A1 A novel c. elegans p21-activated kinase (pak) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of pak activity in the nematode, caenorhabditis elegans |
| 08/31/2006 | WO2006091895A2 Method for the treatment of retinopathy of prematurity and related retinopathic diseases |
| 08/31/2006 | WO2006091871A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 08/31/2006 | WO2006091766A2 Human trophoblast stem cells and use thereof |
| 08/31/2006 | WO2006090933A1 Hepatitis c virus particles and method of proliferating the same |
| 08/31/2006 | WO2006090886A1 Method of analyzing dynamics in the differentiation of vascular endothelial progenitor cells |
| 08/31/2006 | WO2006090882A1 Method for amplification of endothelial progenitor cell in vitro |
| 08/31/2006 | WO2006090750A1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 08/31/2006 | WO2006090745A1 Neurotization promoting agent |
| 08/31/2006 | WO2006090679A1 METHOD FOR DETECTION OF DNA DAMAGE USING Frag1 GENE OR GENE PRODUCT THEREOF AS MARKER |
| 08/31/2006 | WO2006090291A2 Method for expanding cd4+ cd25+ t regulatory cells |